(18)F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center

Por Elliott, Hugh S, Metser, Ur, de Perrot, Marc, Cho, John, Bradbury, Penelope, Veit-Haibach, Patrick, Hussey, Douglas, Noam, Tau
Publicado no Br J Radiol (2018)

Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis

Por Bradbury, Penelope A., Zhai, Rihong, Ma, Clement, Xu, Wei, Hopkins, Jessica, Kulke, Matthew J., Asomaning, Kofi, Wang, Zhaoxi, Su, Li, Heist, Rebecca S., Lynch, Thomas J, Wain, John C, Christiani, David, Liu, Geoffrey
Publicado em 2009

Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis

Por Bradbury, Penelope A., Zhai, Rihong, Hopkins, Jessica, Kulke, Matthew H., Heist, Rebecca S., Singh, Simron, Zhou, Wei, Ma, Clement, Xu, Wei, Asomaning, Kofi, Ter-Minassian, Monica, Wang, Zhaoxi, Su, Li, Christiani, David C., Liu, Geoffrey
Publicado em 2009

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER...

Por Chia, Stephen K., Ellard, Susan L., Mates, Mihaela, Welch, Stephen, Mihalcioiu, Catalin, Miller, Wilson H., Gelmon, Karen, Lohrisch, Caroline, Kumar, Vikaash, Taylor, Sara, Hagerman, Linda, Goodwin, Rachel, Wang, Tao, Sakashita, Shingo, Tsao, Ming S., Eisenhauer, Elizabeth, Bradbury, Penelope
Publicado no Breast Cancer Res (2017)

A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196

Por Leighl, Natasha B., Tsao, Ming-Sound, Liu, Geoffrey, Tu, Dongsheng, Ho, Cheryl, Shepherd, Frances A., Murray, Nevin, Goffin, John R., Nicholas, Garth, Sakashita, Shingo, Chen, Zhuo, Kim, Lucia, Powers, Jean, Seymour, Lesley, Goss, Glenwood, Bradbury, Penelope A.
Publicado no Oncotarget (2017)

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes

Por Bradbury, Penelope A., Kulke, Matthew H., Heist, Rebecca S., Zhou, Wei, Ma, Clement, Xu, Wei, Marshall, Ariela L., Zhai, Rihong, Hooshmand, Susanne M., Asomaning, Kofi, Su, Li, Shepherd, Frances A., Lynch, Thomas J., Wain, John C., Christiani, David C., Liu, Geoffrey
Publicado em 2009

p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis

Por Cescon, David W., Bradbury, Penelope A., Asomaning, Kofi, Hopkins, Jessica, Zhai, Rihong, Zhou, Wei, Wang, Zhaoxi, Kulke, Matthew, Su, Li, Ma, Clement, Xu, Wei, Marshall, Ariela L., Heist, Rebecca Suk, Wain, John C., Lynch, Thomas J., Christiani, David C., Liu, Geoffrey
Publicado em 2009

Genetic associations with sporadic neuroendocrine tumor risk

Por Ter-Minassian, Monica, Wang, Zhaoxi, Asomaning, Kofi, Wu, Michael C., Liu, Chen-Yu, Paulus, Jessica K., Liu, Geoffrey, Bradbury, Penelope A., Zhai, Rihong, Su, Li, Frauenhoffer, Christine S., Hooshmand, Susanne M., De Vivo, Immaculata, Lin, Xihong, Christiani, David C., Kulke, Matthew H.
Publicado em 2011

Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Por Foster, Nathan R., Renfro, Lindsay A., Schild, Steven E., Redman, Mary W., Wang, Xiaofei F., Dahlberg, Suzanne E., Ding, Keyue, Bradbury, Penelope A., Ramalingam, Suresh S., Gandara, David R., Shibata, Taro, Saijo, Nagahiro, Vokes, Everett E., Adjei, Alex A., Mandrekar, Sumithra J.
Publicado no J Thorac Oncol (2015)

Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee

Por Paller, Channing J., Bradbury, Penelope A., Ivy, S. Percy, Seymour, Lesley, LoRusso, Patricia M., Baker, Laurence, Rubinstein, Larry, Huang, Erich, Collyar, Deborah, Groshen, Susan, Reeves, Steven, Ellis, Lee M., Sargent, Daniel J., Rosner, Gary L., LeBlanc, Michael L., Ratain, Mark J.
Publicado em 2014

BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 trial

Por Liu, Geoffrey, Cuffe, Sinead, Liang, Shermi, Azad, Abul Kalam, Cheng, Lu, Brhane, Yonathan, Qiu, Xin, Cescon, David, Bruce, Jeffrey, Chen, Zhuo, Cheng, Dangxiao, Patel, Devalben, Tse, Brandon, Laurie, Scott A., Goss, Glenwood, Leighl, Natasha B., Hung, Rayjean, Bradbury, Penelope A., Seymour, Lesley, Shepherd, Frances A., Tsao, Ming Sound, Chen, Bingshu E., Xu, Wei, Reisman, David
Publicado no Clin Cancer Res (2016)